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Junin virus (JUNV), Machupo virus, Guanarito virus, Sabia virus, and Chapare virus are members of New 
World arenavirus clade B and are the etiological agents of viral hemorrhagic fevers that occur in South 
America. In this study, we produced three monoclonal antibodies (MAbs) to the recombinant nucleocapsid 
protein of JUNV, designated C6-9, Cll-12, and E4-2. The specificity of these MAbs was examined by enzyme- 
linked immunosorbent assay (ELISA), indirect immunofluorescence assay, and an epitope-mapping method. 
Using these MAbs, we developed antigen (Ag) capture ELISA systems. We showed that by using MAb C6-9, 
JUNV Ag was specifically detected. On the other hand, by using MAb Cll-12 or E-4-2, the Ags of all human 
pathogenic South American arenaviruses were detected. The combined use of these Ag capture ELISA systems 
in the present study may be useful for the diagnosis of acute-phase viral hemorrhagic fever due to infection by 
a South American arenavirus.
The South American arenaviruses Junin virus (JUNV), Ma­
chupo virus (MACV), Guanarito virus (GTOV), Sabia virus 
(SABV), and Chapare virus (CHPV) are members of New 
World arenavirus clade B. JUNV, MACV, GTOV, and SABV 
are the etiological agents of Argentine hemorrhagic fever 
(AHF), Bolivian hemorrhagic fever (BHF), Venezuelan hem­
orrhagic fever (VHF), and Brazilian hemorrhagic fever, re­
spectively (4). CHPV was also recently shown to be associated 
with cases of hemorrhagic fever in Bolivia (5). AHF emerged 
in the 1950s, and since then, outbreaks have occurred annually 
without interruption (4). The mortality rate for AHF is esti­
mated to be 15 to 30%, but early treatment with immune 
plasma reduces the rate to less than 1% (6). The region at risk 
has been progressively expanding into northern central Argen­
tina, and almost 5 million people are currently considered to 
be at risk for AHF (6, 13). Phylogenetic analysis indicates that 
JUNV is more closely related to MACV than to SABV or 
CHPV, whereas SABV and CHPV are more closely related to 
each other than to other New World arenaviruses (5).
Arenaviruses are enveloped and contain a bisegmented 
RNA genome. The genome consists of two ambisense single­
stranded RNA molecules, one designated L, which encodes 
the RNA-dependent RNA polymerase and a zinc-binding ma­
trix protein, Z, and the other designated S, which encodes the 
major structural components of the virion, i.e., the nucleocap- 
sid protein (NP) and the envelope glycoprotein precursor (15). 
The arenavirus NP is the most abundant protein among the 
viral structural proteins both in infected cells and in virions (2) 
and is commonly used as a target for detecting viral antigens 
(Ags) (20). Moreover, arenavirus NPs have been known to be 
the most conserved among the same virus species and, to some 
extent, among different arenavirus species (3, 8). Therefore, it 
seems likely that monoclonal antibodies (MAbs) raised against 
the NP of an arenavirus would also be useful for detecting 
other arenaviruses (20). Recently, an immunoglobulin G (IgG) 
enzyme-linked immunosorbent assay (ELISA) was developed 
by using a recombinant NP (rNP) of JUNV, obtained from a 
recombinant baculovirus system, and was proposed to be use­
ful for etiologic confirmation of AHF in seroepidemiological 
studies (20, 26). It is considered that an Ag capture ELISA 
using MAbs specific for viral Ags allows rapid diagnosis of the 
acute phase of viral hemorrhagic fever by detecting viral Ags in 
blood or tissue homogenates (20). In this study, we produced 
MAbs to the rNP of JUNV. These MAbs were characterized 
by ELISA, indirect immunofluorescence assay (IFA), and an 
epitope-mapping method. Ag capture ELISAs were developed 
by using these MAbs that are specific for JUNV and that are 
broadly applicable for the detection of human pathogenic New 
World arenaviruses.
MATERIALS AND METHODS
Cell culture. Hybridomas and their parental cell line, P3/Ag568, were main­
tained in RPMI 1640 medium (Invitrogen Life Technologies, Carlsbad, CA) 
supplemented with 10% fetal bovine serum (FBS), nonessential amino acids 
(Invitrogen), and antibiotics (streptomycin and penicillin G; Invitrogen). Hypo­
xanthine-aminopterin-thymidine supplement (Invitrogen) was added to the me­
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dium for selection of hybridomas, as recommended by the supplier. BTI-TN- 
5B1-4 (High Five; Invitrogen) insect cells were maintained in TC'l00 (Invitrogen) 
supplemented with 10% FBS, 2% tryptose phosphate broth (Difco, Detroit, MI), 
and kanamycin (Invitrogen). HeLa cells were maintained in minimal essential 
medium (Sigma-Aldrich, St. Louis, MO) supplemented with 5% FBS and anti­
biotics (streptomycin and penicillin G; Invitrogen).
Recombinant baculoviruses. The baculoviruses Ac-JUNV-NP and Ac-His- 
Lassa virus (LASV)-NP, expressing the JUNV and His-LASV rNPs, respectively, 
were generated as described previously (20).
The cDNAs of the MACV, GTOV, SABV, and CHPV NPs were obtained by 
chemical synthesis (Codon Devices, Cambridge, MA). The GenBank accession 
numbers of the nucleotide sequences of the MACV, GTOV, SABV, and CHPV 
NP genes are NC_005078, AF485258, NC_006317, and NC_010562, respectively. 
The cDNAs of the MACV, GTOV, SABV, and CHPV NPs were digested with 
BamHI and subcloned into the BamHI restriction site of pAcYM'l (14), and the 
resulting plasmids were designated pAcYM'l-MACV-NP, pAcYMl-GTOV-NP, 
pAcYM'l-SABV-NP, and pAcYM'l-CHPV-NP, respectively. High Five cells 
were transfected with mixtures of linearized BacPAKó DNA (Clontech, Moun­
tain View, CA) and the recombinant transfer vector according to the manufac­
turer’s instructions and the procedures described by Kitts and Possee (10), and 
recombinant baculoviruses were obtained from them. The baculoviruses express­
ing the MACV, GTOV, SABV, and CHPV rNPs were designated Ac-MACV- 
NP, Ac-GTOV-NP, Ac-SABV-NP, and Ac-CHPV-NP, respectively.
Expression and purification of rNPs. High Five cells infected with Ac-JUNV- 
NP, Ac-MACV-NP, Ac-GTOV-NP, Ac-SABV-NP, Ac-CHPV-NP, or Ac-His- 
LASV-NP were incubated at 26°C for 72 h. The cells were then washed twice 
with cold phosphate-buffered saline (PBS) solution. The High Five cells were 
lysed in PBS containing 1% NP-40 and 2 M urea. After the cell lysates were 
centrifuged at 15,000 X g for 10 min, the pellet fractions were collected and then 
solubilized in PBS containing 8 M urea. After the samples were centrifuged, the 
supernatant fractions were used as the purified Ags. The control Ag was pro­
duced from High Five cells infected with Ac-AP, which lacks the polyhedrin gene, 
in the same manner as for the negative control Ags. Al Ags were aliquoted and 
kept at -80°C until use.
Establishment of MAbs. BALB/c mice were immunized three times with the 
purified JUNV rNP. Spleen cells were obtained 3 days after the last immuniza­
tion and fused with P3/Ag568 cells by using polyethylene glycol (Invitrogen). The 
culture supernatants of the hybridoma cells were screened by ELISA with puri­
fied JUNV rNP as an Ag in the presence of 2 M urea. MAbs were purified from 
the culture supernatant by using a MAbTrap GII antibody purification kit (GE 
Healthcare Bio-Sciences, Piscataway, NJ) according to the manufacturer’s in­
structions. The concentration of each purified MAb was also determined by use 
of a Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA) according to 
the manufacturer’s instructions.
Polyclonal antibodies. Polyclonal antibodies were induced in rabbits by im­
munization with the purified rNPs of JUNV, MACV, GTOV, SABV, and 
CHPV, respectively. Rabbit sera collected before immunization were used as 
controls.
IgG ELISA. The IgG ELISA was performed as previously described, except for 
Ag preparation (20-22). Briefly, ELISA plates (96 wells, Pro-Bind; Falcon; 
Becton Dickinson Labware, Franklin Lakes, NJ) were coated with the predeter­
mined optimal quantity of purified JUNV, MACV, GTOV, SABV, CHPV, or 
His-LASV rNP (approximately 100 ng/well) at 4°C overnight. Then, each well of 
the plates was covered with 200 pl of PBS containing 5% skim milk and 0.05% 
Tween 20 (PBST-M), followed by incubation for 1 h for blocking at 37° C. The 
plates were washed three times with PBS containing 0.05% Tween 20 (PBST) 
and then inoculated with MAbs (100 pl/well), which were diluted 1:1,000 with 
PBST-M. Ater a 1-h incubation period, the plates were washed three times with 
PBST and then the plates were inoculated with goat anti-mouse IgG antibody 
labeled with horseradish peroxidase (HRP; 1:1,000 dilution; Zymed Laborato­
ries, Inc., South San Francisco, CA). Ater a further 1-h incubation period, the 
plates were washed and 100 pl of ABTS [2,2'azinobis(3-ethylbenzthiazolinesul- 
fonic acid)] solution (Roche Diagnostics, Mannheim, Germany) was added to 
each well. The plates were incubated for 30 min at room temperature, and the 
optical density at 405 nm (OD405) was measured against a reference of 490 nm. 
The adjusted OD405 value was calculated by subtracting the OD405 value of the 
negative Ag-coated wells from that of the corresponding wells.
IFA. The full-length cDNA of the JUNV NP obtained from Ac-JUNV-NP, 
which possessed a BamHI restriction site at both extremities, was cloned into the 
BamHI site of the pKS336 vector (23), and the resulting plasmid was designated 
pKS-JUNV-NP. Aso, the chemically synthesized full-length cDNA of the 
MACV, GTOV, SABV, and CHPV NPs were cloned into the BamHI site of the 
pKS336 vector and the resulting plasmids were designated pKS-MACV-NP, 
pKS-GTOV-NP, pKS-SABV-NP, and pKS-CHPV-NP, respectively. HeLa cells 
were then transfected with each of these expression plasmids by using a trans­
fection reagent (FuGENEó; Roche Diagnostics) according to the manufacturer’s 
instructions. The transfected cells were selected with 4 pg of blasticidin S- 
hydrochloride/ml in culture medium. The HeLa cell clones were obtained by 
analyzing the expression of each rNP by IFA with rabbit serum raised against the 
JUNV, MACV, GTOV, SABV, or CHPV rNP, as previously described (20).
Ag capture ELISA. Purified MAb C6-9, Cl 1-12, or E4-2 was used to coat 
microwell immunoplates (Falcon; Becton Dickinson Lab ware) at 100 ng/well in 
100 pl of PBS at 4 C overnight, followed by blocking with PBST-M for 1 h at 
room temperature. After the plates were washed with PBST, 100 pl of samples 
containing serially diluted rNP of JUNV, MACV. GTOV, SABV, CHPV, or 
LASV was added and the plates were incubated for 1 h at 37°C. The plates were 
then washed with PBST, and 100 pl of rabbit polyclonal antibody raised against 
the rNP of JUNV diluted 1:500 with PBST-M was added to each well. Ater 1 h 
of incubation at 37°C, the plates were washed with PBST, and HRP-conjugated 
goat anti-rabbit IgG (Zymed, San Francisco, CA) was added. The plates were 
incubated for 1 h at room temperature. After another extensive washing with 
PBST, 100 pl of ABTS substrate solution (Roche Diagnostics) was added and 
the OD405 was measured with a reference wavelength of 490 nm after 30 min of 
incubation at room temperature. A a negative control, the OD of control 
Ag-inoculated wells was measured. The adjusted OD405 values were calculated 
by subtracting the OD405 value of the negative control well from the correspond­
ing OD405 values. Means and standard deviations were calculated from the ODs 
of 12 negative control wells, and the cutoff value for the assay was defined as the 
mean plus 3 standard deviations.
Expression of truncated rNPs of JUNV. In order to determine the epitope on 
the JUNV rNP for the MAbs, a series of truncated JUNV rNPs were expressed 
as fusion proteins with glutathione 5-transferase (GST). The DNA correspond­
ing to each of the truncated NP fragments was amplified by PCR with specifically 
designed primer sets. The amplified DNA was subcloned into the BamHI and 
EcoRI cloning sites of plasmid pGEX-2T (Amersham Pharmacia Biotech, Buck­
inghamshire, England). The GST-tagged full-length rNP (GST-JUNV frNP) or 
truncated forms of the rNP (GST-JUNV trNPs) were expressed in Escherichia 
coli BL21 and then partially purified.
Western blotting. The MAbs were tested for reactivity to GST-JUNV frNP 
and a series of GST-JUNV trNPs by Western blotting as reported previously (9, 
18, 24).
MAb epitope mapping. The epitopes for MAbs C6-9 and C'11-12 were deter­
mined by epitope-blocking ELISA using synthetic peptides. The decapeptides 
were chemically synthesized by shifting one amino acid, with a consecutive 
overlap of nine amino acids to cover the JUNV NP (amino acids [aa] 5 to 26 for 
C6-9 and aa 543 to 564 for C'11-12). ELISA plates were coated with purified 
JUNV rNP prepared by using a baculovirus expression system (approximately 
100 ng/well) at 4°C overnight. Then, each well of the plates was inoculated with 
200 pl of PBS-M, followed by incubation for 1 h for blocking. MAb C6-9 or 
C-ll-12 was mixed with each peptide (1 pg/well) and incubated for 1 h at 37°C, 
and then the mixture was added to each well of the plates. Ater a 1-h incubation 
period, the plates were washed three times with PBST, and then the plates were 
inoculated with goat anti-mouse IgG antibody labeled with HRP (1:1,000 dilu­
tion; Zymed). The following procedure was performed as described in the IgG 
ELISA section above.
For MAb E4-2, the epitope was determined by ELISA using GST-JUNV frNP 
and trNPs. ELISA plates were coated with purified GST-JUNV frNP or trNPs 
(approximately 100 ng/well) according to the method described in the IgG 
ELISA section above. MAb E4-2 or an anti-GST MAb was used for detection at 
a 1:2,000 or a 1:500 dilution, respectively. The adjusted OD405 was calculated by 
dividing the OD405 of MAb E4-2 by that of the anti-GST MAb from the corre­
sponding wells.
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RESULTS
Generation of MAbs. In order to obtain MAbs against the 
JUNV NP, BALB/c mice were immunized with the purified 
rNP of JUNV. The MAbs were purified and tested for reac­
tivity to the rNP of JUNV by IgG ELISA. Three MAbs, des­
ignated MAb C6-9, MAb Cl 1-12, and MAb E4-2, reacted with 
the rNP of JUNV by IgG ELISA even in the presence of 2 M 
urea.
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FIG. 1. Reactivity of each MAb with arenavirus rNP. Each purified 
rNP (100 ng/well) was used to coat microplates as described in the text, 
and the reactivities of each MAb to the rNPs of JUNV, MACV, 
GTOV, SABV, CHPV, and LASV were measured. The MAbs are 
shown on the .v axis. Results are expressed as the OD^.
Reactivities of MAbs to rNPs of arenaviruses. The reactiv­
ities of MAbs to the rNPs of human pathogenic arenaviruses 
were examined by ELISA. MAb C6-9 reacted specifically with 
the rNP of JUNV but did not react with those of the other 
pathogenic South American arenaviruses (Fig. 1). On the 
other hand, MAb Cll-12 reacted at the same level with the 
rNPs of all of the pathogenic South American arenaviruses, 
including JUNV, GTOV, MACV, SABV, and CHPV. MAb 
E4-2 reacted strongly with the rNP of JUNV, slightly more 
weakly with those of GTOV, MACV, and SABV, and very 
weakly with that of CHPV. However, MAb E4-2 reacted 
clearly with the rNP of CHPV when ELISA plate wells were 
coated with more-concentrated CHPV Ag (data not shown). 
None of the three MAbs reacted with the rNP of the human 
pathogenic Old World arenavirus LASV.
Reactivity was also examined by IFA. Consistent with the 
ELISA result, MAb C6-9 reacted only with HeLa cells express­
ing the 1NP of JUNV and MAb Cll-12 reacted with HeLa 
cells expressing the rNPs of all of the pathogenic South Amer­
ican arenaviruses (Table 1). On the other hand, MAb E4-2, 
which showed cross-reactivity to other arenaviruses by ELISA, 
reacted only with HeLa cells expressing the rNP of JUNV 
(Table 1). None of the three MAbs reacted with LASV NP- 
expressing HeLa cells (Table 1).
Development of Ag capture ELISAs. Ag capture ELISAs 
were developed by using three MAbs as capture antibodies, 
and sensitivity and specificity were determined. The Ag cap­
ture ELISA with MAb C6-9 specifically detected the rNP of
Reactivity" with NP of:
MAb ---------------------------------------------------------------------------------------
JUNV MACV GTOV SABV CHPV LASV
TABLE 1. MAb reactivity with NPs of arenaviruses in IFA
C6-9 + - - - - -
Cll-12 + + + + + -
E4-2 + - - - - -
" The symbols + and — indicate positive and negative reactions, respectively. 
The expression of each NP in HeLa cells was confirmed by IFA with a rabbit 
polyclonal antibody produced against each NP.
o 
o
rNP (ng/well)
10 10 00 e-j <0 co 0> 10
CJ to 00 o 0) ■'t CM
<0 V-Z 10 K co o' Ô Ôco —
FIG. 2. Reactivity of each MAb in an Ag capture ELISA. Purified 
MAbs C6-9 (A), Cll-12 (B), and E4-2 (C) were used to coat micro­
plates as described in the text, and their abilities to capture the rNPs 
of JUNV, MACV, GTOV, SABV, CHPV, and LASV were examined 
at various concentrations in the Ag capture format. Results are ex­
pressed as the OD405.
JUNV, whereas it could not detect the rNPs of the other South 
American arenaviruses. No less than 62.5 ng/well of the rNP of 
JUNV was detected by the Ag capture ELISA using MAb C6-9 
(Fig. 2A). On the other hand, the Ag capture ELISAs using
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FIG. 3. Reactivities of MAbs C6-9, Cll-12, and E4-2 with the GST-tagged JUNV NP by Western blotting. Schematic drawings of polypeptides 
of the JUNV NP and the amino acid positions of the polypeptides are shown on the left. The reactivities of MAbs and a control MAb against GST 
to these polypeptides by Western blotting are shown on the right. The asterisks indicate the polypeptides to which the MAbs reacted.
MAbs Cll-12 and E4-2 were more sensitive at detecting the 
rNP of JUNV, with detection limits of 7.82 and 3.91 ng/well, 
respectively, and these Ag capture ELISAs also detected the 
rNPs of the other South American arenaviruses GTOV, 
MACV, SABV, and CHPV (Fig. 2B and C). In contrast, the 
LASV NP was not detected by any of the Ag capture ELISAs.
Determination of the epitope on the JUNV rNP recognized 
by the MAbs. In order to determine regions including epitopes 
on the JUNV rNP recognized by the MAbs, the reactivity of 
these MAbs was tested by Western blotting using the GST- 
JUNV frNP and a series of GST-JUNV trNPs as Ags. MAb 
C6-9 reacted with GST-JUNV frNP and trNPs at aa 384 to 564 
and 524 to 564 (Fig. 3). MAb Cll-12 reacted with GST-JUNV 
frNP and trNPs at aa 1 to 235 and 1 to 59 (Fig. 3). MAb E4-2 
reacted with GST-JUNV frNP and trNPs at aa 1 to 235 and 54 
to 117 (Fig. 3).
To further determine exact epitope positions on the rNP of 
JUNV, we performed epitope-blocking ELISAs with a series 
of overlapping synthetic peptides. As shown in Fig. 4A, pep­
tides containing PPSLLFLP (aa 551 to 558) blocked the reac­
tion of MAb C6-9 with the purified rNP of JUNV. Similarly, 
peptides containing WTQSLR (aa 12 to 17) blocked the reac­
tion of MAb Cll-12 with the purified rNP of JUNV (Fig. 4B).
Because the epitope recognized by MAb E4-2 could not be 
determined by epitope-blocking ELISA, it was analyzed more 
in detail by using a series of GST-JUNV trNPs by ELISA (Fig. 
4C). The reactivity of MAb E4-2 was normalized by dividing 
the OD405 value of MAb E4-2 by that of an anti-GST MAb. 
MAb E4-2 reacted with the GST-JUNV trNP containing the 
polypeptide KEVDRLMS (aa 72 to 79). The ELISA result was 
consistent with that of Western blotting (data not shown). The 
epitopes recognized by the MAbs are summarized in Fig. 5.
DISCUSSION
Detection of a viral Ag and/or the viral genome is crucial for 
rapid diagnosis of patients with hemorrhagic fever caused by 
South American arenaviruses, especially for patients in the 
acute phase. The application of reverse transcriptase PCR 
(RT-PCR) and TaqMan PCR for detection of the JUNV, 
MACV, and GTOV genomes has been reported (1,11,12, 27). 
Serological diagnosis is also useful for the diagnosis of AHF, 
especially in patients in the convalescent phase (7,17,19, 20, 26).
An Ag capture ELISA using a cocktail of MAbs against 
JUNV (25) was applied in an epidemiological study of rodents 
in Argentina (16). MAbs reactive with the NP of JUNV have 
been shown to cross-react with those of MACV and other 
nonpathogenic arenaviruses (25). In the present study, by using 
MAbs raised against the rNP of JUNV, we developed Ag 
capture ELISAs specific for JUNV and broadly reactive to 
human pathogenic New World arenaviruses.
The three MAbs to JUNV NP (designated C6-9, Cll-12, 
and E4-2) reacted with the rNP of JUNV prepared using a 
baculovirus expression system by IgG ELISA and with rNP 
expressed in mammalian cells by IFA (Fig. 1 and Table 1). All 
Ag capture ELISAs using MAbs E4-2, Cll-12, and C6-9 de­
tected the rNP of JUNV (Fig. 2), suggesting that these ELISAs 
are useful tools for the diagnosis of AHF.
Interestingly, an Ag capture ELISA using MAb E4-2 de­
tected the Ags of all of the pathogenic South American arena­
viruses tested, in addition to that of JUNV (Fig. 2). IgG ELISA 
showed that the reactivity of MAb E4-2 with the rNP of JUNV 
was stronger than that with the rNPs of other South American 
arenaviruses (Fig. 1). The minimal length of the epitope re­
quired to be recognized by MAb E4-2 was 8 aa with the se­
quence KEVDRLMS (Fig. 4 and 5). However, the GST-JUNV 
trNP at aa 1 to 80 was more reactive than that at aa 1 to 79, 
which includes minimal epitope sequences, but was still less 
reactive than those at aa 72 to 564, 67 to 564, and 1 to 564 (Fig. 
4). Even though we could not express GST-JUNV trNPs at aa 
1 to 81 or more in E. coli because of their toxicity, it is possible 
that some additional amino acids at the C terminus of the 
minimal epitope are required for complete reaction with MAb 
E4-2. Actually, comparison of the amino acid sequences of NPs 
at positions 72 to 83 among South American arenaviruses 
showed that the amino acid differences with respect to JUNV 
were 1 aa for GTOV, 2 aa for MACV, 3 aa for SABV, and 5 
aa for CHPV (Fig. 5), and these differences correlated well 
with the levels of reactivity of MAb E4-2 to the rNPs of the 
viruses (Fig. 1).
The Ag capture ELISA using MAb Cll-12 also detected the 
Ags of all of the other pathogenic South American arenavi­
ruses (Fig. 2). MAb Cll-12 reacted with the rNPs of all of the 
pathogenic South American arenaviruses by IgG ELISA and 
IFA (Fig. 1 and Table 1). These results suggest that MAb 
Cll-12 would be useful for detecting the Ags of all South 
American arenaviruses by Ag capture ELISA and IFA. Fur­
thermore, the amino acid sequence (WTQSLR) of the epitope 
recognized by MAb Cll-12 was located at the N terminus of 
the JUNV NP and was conserved among all of the pathogenic
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South American arenavirus isolates so far deposited in GenBank 
(Fig. 5). However, slight differences in the sensitivity of detec­
tion of the NPs of the South American arenaviruses by Ag 
capture ELISA were observed. This may be due to the reac­
tivity of the detector antibody, anti-JUNV NP rabbit serum, 
which was raised against the purified rNP of JUNV. Since the 
N-terminal region of the NPs recognized by MAbs Cll-12 and 
E4-2 (aa 1 to 80) was relatively conserved among the NPs of 
South American arenaviruses, Ag capture ELISAs using MAbs 
Cll-12 and E4-2 are considered to be useful for detecting most 
South American arenavirus isolates. Therefore, these Ag cap­
ture ELISAs may be applicable not only for the diagnosis of 
AHF but also for the diagnosis of BHF, VHF, and Brazilian 
hemorrhagic fever and may also be applicable for newly emerg­
ing viral hemorrhagic fevers caused by CHPV, although fur­
ther study is needed.
KEVPSFRWTQ 
EVPSFRWTQS 
VPSFRKJTQSL 
psfrswBr 
CF ROTASI, RR 
fr.btqslk:-: 4 
RfilïlQSIiRRGL 
WrgSERRGLS 
TQSLRRGLSQ 
QSLRRGLSQF 
SLRRGLSQFT 
LRRGLSQFTQ 
RRGLSQFTQT 
DELMELASDL
0.5 1 1.50
FIG. 4. Determination of the epitope on JUNV NP recognized by MAbs C6-9 (A), Cll-12 (B), and E4-2 (C). (A, B) The ability of synthetic 
decapeptides to block the reactivity of MAbs to the JUNV rNP was examined by ELISA. The amino acid sequences and positions of synthetic 
peptides used in the assay are shown on the y axis. The synthetic peptides at aa 1 to 10 and 97 to 106 were used as negative control peptides for 
MAbs C6-9 and Cll-12, respectively. Results indicate the OD405. MAb C6-9 was confirmed to react with the 8 aa residues (PPSLLFLP) at positions 
551 to 558, as represented by the shaded box (A). Similarly, MAb Cll-12 was confirmed to react with the 6 aa residues (WTQSLR) at positions 
12 to 17 (B). (C) The reactivity of MAb E4-2 with GST-tagged partial polypeptides of the JUNV NP was examined by ELISA. Schematic drawings 
of polypeptides of the JUNV NP are shown on the left, and the amino acid positions of the polypeptides are indicated on the y axis. NC represents 
the GST protein without any JUNV NP sequences. The reactivity of MAb E4-2 to each partial JUNV NP is indicated by the adjusted OD405, which 
was calculated by dividing the OD405 of MAb E4-2 by that of the anti-GST MAb to the corresponding Ag. MAb E4-2 was confirmed to react with 
the 8 aa residues (KEVDRLMS) at positions 72 to 79, as indicated at the bottom.
On the other hand, the Ag capture ELISA using MAb C6-9 
only detected JUNV Ag (Fig. 2). Furthermore, MAb C6-9 only 
reacted with the rNP of JUNV by IgG ELISA and IFA (Fig. 1 
and Table 1). The amino acid sequence (PPSLLFLP) of the 
epitope recognized by MAb C6-9 was conserved among JUNV 
isolates so far deposited in GenBank (data not shown) but 
differed from those of other South American arenavirus iso­
lates (Fig. 5). Since only the proline at position 552 in the 
epitope sequence is different in MACV, this proline is likely to 
be critical in the reaction of MAb C6-9. Therefore, the Ag 
capture ELISA using MAb C6-9 may detect most, if not all, 
JUNV isolates. Considering that the symptoms due to JUNV 
infection in humans are indistinguishable from those due to 
other South American arenaviruses, the Ag capture ELISA 
using MAb C6-9 may be a useful diagnostic tool, especially 
for AHF.
Downloaded from http://cvi.asm
.org/ on August 23, 2019 by guest
Vol. 16, 2009 ANTIGEN CAPTURE ELISA FOR SOUTH AMERICAN ARENAVIRUSES 1137
C11-12 E4-2
A A
C6-9
A
\ __ ****••»
12 17 72 79/80 83 551 558
JUNV: WTQSLR KEVDRLMSMRSV PPSLLFLP
MACV: WTQSLR KEVDRLMSMKSI PLSLLFLP
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FIG. 5. Schematic representation of epitopes of the JUNV NP recognized by MAbs. The amino acid sequences of the epitopes of the JUNV 
NP recognized by MAbs C6-9, Cl 1-12, and E4-2 are in boldface, and the amino acid positions are shown above the sequence. The amino acid 
sequences of the epitopes are compared to those of MACV, GTOV, SABV, and CHPV. The amino acid residues different from those of the JUNV 
NP are underlined. Because the amino acid sequence of the corresponding region is conserved among the strains of each virus species, a single 
sequence represents each virus species. The GenBank accession numbers for the S genes of JUNV are NC_005081, DQ272266, AY746353, 
AY619641, AY358023, D10072, U70802, U70803, and U70804. Those for the S genes of MACV are NC_005078, AY924208, AY924207, 
AY924206, AY924205, AY924204, AY924203, AY924202, AY571959, AY624355, AY619645, AY571904, AF485260, and AY129248. Those for 
GTOV are NC_005077, AY497548, AF485258, and AY129247. Those for SABV and CHPV are NC_006317 and NC_010562, respectively.
While the efficacy of newly developed Ag capture ELISAs in 
the diagnosis of viral hemorrhagic fever caused by South 
American arenaviruses was not evaluated by using serum sam­
ples from patients, it is generally accepted that an Ag capture 
ELISA is useful for the detection of viral Ags in blood and/or 
organ tissue specimens from patients in the acute phase.
The amino acid sequences of the epitope regions recognized 
by MAbs E4-2 and C6-9 were different from those of the 
corresponding region of LASV. On the other hand, the amino 
acid sequence (WTQSLR) of the epitope recognized by MAb 
Cl 1-12 is the same in JUNV and LASV, even though the MAb 
failed to react to the LASV NP. However, aa 8 and 11 are 
proline and arginine in the NPs of South American arenavi­
ruses while they are lysine/arginine and leucine in the LASV 
NP, respectively. Thus, it is possible that some amino acid 
sequence differences around the minimal epitope region affect 
the reaction with MAb Cll-12.
In general, RT-PCR is more sensitive in detecting viruses in 
patients’ specimens than is an Ag capture ELISA. Recently, a 
real-time RT-PCR has been established for the detection of all 
of the pathogenic South American arenaviruses, but it has not 
yet been applied for clinical specimens, so the possibility that it 
does not detect novel virus strains or species cannot be ruled 
out (27). Furthermore, arenaviruses are known to have high 
genetic variability, and false-negative results are occasionally 
obtained with some particular primer sets for RT-PCR. On the 
other hand, the Ag capture ELISAs established in the present 
study recognized highly conserved epitopes, suggesting that Ag 
capture ELISA may be useful for the diagnosis of suspected 
patients.
In conclusion, we developed Ag capture ELISA systems 
using newly produced MAbs against the JUNV NP and showed 
that JUNV Ag was detected specifically by the Ag capture 
ELISA using MAb C6-9. On the other hand, the Ags of all 
human pathogenic South American arenaviruses could be de­
tected by an Ag capture ELISA using MAb Cll-12 or E-4-2. 
The combined use of these Ag capture ELISAs in the present 
study may be useful for the diagnosis and differentiation of 
viral hemorrhagic fevers caused by South American arenavirus 
infections.
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